Skip to main content

ONCOLYTICS BIOTECH INC insider trading

ONCYNASDAQ
$0.63-0.01 (-1.56%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-55.6%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Unlock quarterly net flow

Key players

  • BRBernd R. SeizingerDirector0.4447%of company
  • WPWayne PisanoDirector0.3862%of company
  • KLKirk LookChief Financial Officer0.2255%of company
  • TCThomas Charles HeinemanChief Medical Officer0.2218%of company
  • AHAngela HolthamDirector0.144%of company
  • AHAllison HagermanChief Technology Officer0.0902%of company
  • JKJared KellyChief Executive Officer0.0894%of company
  • DMDeborah Margaret BrownDirector0.0862%of company
  • PSPatricia S. AndrewsDirector0.0613%of company
  • AAAndrew AromandoChief Business Officer0.0432%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
ONCYJared KellyChief Executive OfficerOpen market purchase$4.85K+4.6%$0.96$4.85KMar 12, 2026Mar 13, 2026
ONCYJames T. ParsonsDirectorOpen market purchase$10.3K+31.4%$1.03$10.3KMar 11, 2026Mar 13, 2026
ONCYBernd R. SeizingerDirectorOpen market purchase$34K+7.6%$0.85$34KFeb 12, 2026Feb 13, 2026
ONCYWayne PisanoDirectorOpen market purchase$25.2K+6.5%$0.84$25.2KFeb 12, 2026Feb 13, 2026
ONCYKirk LookChief Financial OfficerOpen market purchase$10.1K+4.4%$0.84$10.1KFeb 12, 2026Feb 13, 2026
ONCYJared KellyChief Executive OfficerOpen market purchase$24.8K+37.1%$0.84$24.8KFeb 12, 2026Feb 13, 2026
ONCYThomas Charles HeinemanChief Medical OfficerOpen market purchase$10.1K+4.5%$0.83$10.1KFeb 12, 2026Feb 13, 2026
ONCYAllison HagermanVP, Product DevelopmentOpen market purchase$8.3K+9.5%$0.83$8.3KFeb 12, 2026Feb 13, 2026
ONCYDeborah Margaret BrownDirectorOpen market purchase$21.3K+29.5%$0.85$21.3KFeb 12, 2026Feb 13, 2026
ONCYPatricia S. AndrewsDirectorOpen market purchase$30.4K+82.9%$0.86$30.4KFeb 12, 2026Feb 13, 2026
ONCYBernd R. SeizingerDirectorOpen market purchase$49.8K+12.9%$0.83$49.8KFeb 11, 2026Feb 13, 2026
ONCYJared KellyChief Executive OfficerOpen market purchase$4.7K+7.6%$0.84$4.7KFeb 11, 2026Feb 13, 2026
ONCYAndrew AromandoChief Business OfficerOpen market purchase$25.5K+116.1%$0.86$25.5KFeb 11, 2026Feb 13, 2026
ONCYBernd R. SeizingerDirectorOpen market purchase$104K+27.3%$1.04$104KJan 16, 2026Jan 20, 2026
End of history · 14 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.